Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01584518 · ClinicalTrials.gov registry record · NA
B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading
A NA study, sponsored by Creighton University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01584518 is a NA study that has completed, run by Creighton University. The registered enrollment target is 50 participants.
The verdict
NCT01584518, a NA study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The long-range goal of this proposal is to decrease morbidity and mortality related to pulmonary edema and congestive heart failure (CHF) in post-operative patients. The short-range goal is to determine a mechanistic endpoint when therapy for impending heart failure can be initiated and terminated based on B-type natriuretic peptide (BNP) levels. The investigators propose to utilize changing levels of BNP as a surrogate marker for CHF.
Interventions
- DRUG Furosemide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01584518
The ClinicalTrials.gov registry entry for NCT01584518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Furosemide is the first listed.
NCT01584518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01584518 about?
NCT01584518 is a clinical study titled "B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading". The long-range goal of this proposal is to decrease morbidity and mortality related to pulmonary edema and congestive heart failure (CHF) in post-operative patients. The short-range goal is to determine a mechanistic endpoint when therapy for impending heart failure can be initiated and terminated b...
What is the current status of trial NCT01584518?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2012-07. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01584518?
The interventions under investigation include: Furosemide (DRUG).
Who is sponsoring clinical trial NCT01584518?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.